Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 97,433	$ 111,707
Allowance for credit losses	19	22	$ 19	$ 13
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 288	$ 487
Stockholders’ Equity
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	40,000	40,000
Preferred stock, outstanding (in shares)	40,000	40,000
Common stock, authorized (in shares)	800,000,000	800,000,000
Common stock, issued (in shares)	169,666,137	169,220,511
Common stock, outstanding (in shares)	169,666,137	169,220,511	177,193,515	192,329,691
Series C Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)	20,000	20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)		20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000